Contract 36E79725A0009
Merz Pharmaceuticals, Llc · Department Of Veterans Affairs · March 12, 2025
Merz Pharmaceuticals, Llc was awarded a federal contract by Department Of Veterans Affairs on March 12, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. This is a task or delivery order issued under parent IDIQ 36F79719D0246. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 29, 2026. If all options are exercised, the contract could reach $12.06 million.
Contract details
- PIID
- 36E79725A0009
- Parent IDIQ
- 36F79719D0246
- Award type
- Bpa
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- March 12, 2025
- Latest action
- January 29, 2026
Description
EXERCISE OPTION YEAR 1 - BPA 36E79725A0009
Modification timeline
-
January 29, 2026Mod P00002 · Exercise An Option$0
-
December 10, 2025Mod P00001 · Supplemental Agreement For Work Within Scope2026 PUBLIC LAW PRICING UPDATES.$0
-
March 12, 2025Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79725A0009?
Contract 36E79725A0009 is a federal contract awarded to Merz Pharmaceuticals, Llc by Department Of Veterans Affairs on March 12, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36E79725A0009?
Merz Pharmaceuticals, Llc won contract 36E79725A0009 from Department Of Veterans Affairs.
How much is contract 36E79725A0009 worth?
Contract 36E79725A0009 has obligated $0 to date but carries a potential ceiling of $12.06 million if fully funded and all options are exercised.